BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30849255)

  • 21. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
    Breccia M; Lo Coco F
    Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
    Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
    Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
    Rajpurkar M; Alonzo TA; Wang YC; Gerbing RB; Gamis AS; Feusner JH; Gregory J; Kutny MA
    J Pediatr Hematol Oncol; 2019 Jan; 41(1):51-55. PubMed ID: 30095694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
    Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
    Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience.
    Jeddi R; Ghédira H; Menif S; Ben Neji H; Ben Amor R; Kacem K; Aissaoui L; Bouteraâ W; Abdennebi Y; Raihane BL; Gouider E; Raouf H; Hèla BA; Saad A; Zaher B; Meddeb B
    Hematology; 2010 Aug; 15(4):204-9. PubMed ID: 20670478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
    Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
    Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleeding and thrombosis in acute promyelocytic leukemia.
    Choudhry A; DeLoughery TG
    Am J Hematol; 2012 Jun; 87(6):596-603. PubMed ID: 22549696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe hemorrhagic complications during remission induction therapy for acute promyelocytic leukemia: incidence, risk factors, and influence on outcome.
    Yanada M; Matsushita T; Asou N; Kishimoto Y; Tsuzuki M; Maeda Y; Horikawa K; Okada M; Ohtake S; Yagasaki F; Matsumoto T; Kimura Y; Shinagawa K; Iwanaga M; Miyazaki Y; Ohno R; Naoe T
    Eur J Haematol; 2007 Mar; 78(3):213-9. PubMed ID: 17241371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.
    Kawano N; Kuriyama T; Yoshida S; Yamashita K; Ochiai H; Nakazaki S; Tasaki A; Ueda A
    Intern Med; 2013; 52(1):55-62. PubMed ID: 23291674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombomodulin alfa treatment in patients with acute promyelocytic leukemia and disseminated intravascular coagulation: a retrospective analysis of an open-label, multicenter, post-marketing surveillance study cohort.
    Matsushita T; Watanabe J; Honda G; Mimuro J; Takahashi H; Tsuji H; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 May; 133(5):772-81. PubMed ID: 24636871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
    Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
    J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.
    Hou W; Zhang Y; Jin B; Cao W; Lu M; Yan L; Yang H; Tian X; Hou J; Fu J; Zhao H; Li H; Zhou J
    Blood Cells Mol Dis; 2019 Nov; 79():102351. PubMed ID: 31400712
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse pulmonary alveolar hemorrhage in acute promyelocytic leukemia.
    Saka H; Ito T; Ito M; Watanabe A; Shimokata K
    Intern Med; 1992 Apr; 31(4):457-8. PubMed ID: 1633346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of fibrinogen in early bleeding of patients with newly diagnosed acute promyelocytic leukemia.
    Chu T; Wang H; Lv X; Qi J; Tang Y; Fan Y; Qiu H; Tang X; Fu C; Ruan C; Han Y; Wu DP
    Platelets; 2021 Jul; 32(5):677-683. PubMed ID: 32799612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
    Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
    Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coagulopathy and differentiation syndrome: the main complications of the initial treatment of acute promyelocytic leukemia].
    Korístek Z; Zák P
    Vnitr Lek; 2008; 54(7-8):745-50. PubMed ID: 18780573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulopathy of acute promyelocytic leukemia.
    Falanga A; Barbui T
    Acta Haematol; 2001; 106(1-2):43-51. PubMed ID: 11549776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cerebral infarction as the first symptom in acute promyelocytic leukemia: A case report and literature review.
    Zhao C; Xie X; Ge D; Wu D; Xie Q; Xin H; Yang T
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Apr; 45(4):476-480. PubMed ID: 32879075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
    Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
    Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.